A new scientific review highlights the potential of CBD to treat and manage the symptoms of conditions like epilepsy, pain, cancer, schizophrenia, diabetes and COVID-19, among others.
The study, “Beneficial effects of cannabidiol from Cannabis,” was published last month in the journal Applied Biological Chemistry. In addition to the overview of cannabis on human health, it “delves into recent CBD research advancements, highlighting the compound’s potential medical applications.” It features sections on cannabinoids as treatment for the form of epilepsy known as Dravet syndrome, as a promising pain relief alternative, as a way to manage the symptoms of schizophrenia and even as a possible inhibitor of COVID-19 infection. It also touches on “the diverse anticancer properties of cannabinoids” that authors said present “promising opportunities for future therapeutic interventions in cancer treatment,” as well as CBD’s apparent effects on diabetes-related biological processes.
The results of the study showed that CBD in some way or another was helpful for just about all participants across all disorders. Whether it was for pain management, relaxation, or sleep, CBD showed positive results. The amount of CBD one should take is dependent on several factors, and one should consult with a doctor before using it.
